Table 3 Changes in medication among patients taking insulin at baseline
Participant | Week 0: Total daily dose | Week 24: Total daily dose |
|---|---|---|
Low-glycemic, reduced-calorie diet group (total n = 29) | ||
1 | insulin 24 units | none |
| Â | insulin sliding scale three times a day | none |
2 | insulin 85 units | insulin 13 units |
3 | insulin 160 units | insulin 120 units |
Low-carbohydrate, ketogenic diet group (total n = 21) | ||
1 | insulin 50 units | none |
2 | insulin 90 units | none |
3 | insulin 32 units | none |
| Â | rosiglitizone 4 mg/metformin 2000 mg | metformin 1000 mg |
4 | insulin 40 units | none |
| Â | metformin 2000 mg | metformin 2000 mg |
5 | insulin 40 units | insulin 35 units |
| Â | insulin sliding scale three times a day | none |
6 | insulin 120 units | insulin 90 units |
| Â | metformin 2000 mg | metformin 2000 mg |
7 | insulin 135 units | insulin 60 units |
8 | insulin 80 units | insulin 8 units |
| Â | pioglitazone 45 mg | pioglitazone 45 mg |
| Â | glimiperide 8 mg | glimiperide 8 mg |